Dividend Focus Stock: Attractive Yield Supported by an Evergreen Pharmaceutical Business
The maker of a leading cosmetic treatment offers an attractive yield underpinned by an anti-inflammatory franchise that appears forever young.
The healthcare sector is rich with high-yielding companies, but our Dividend Informer analysts name this large-cap biopharmaceutical as one of their favorites.
In order to read the full analysis on this featured dividend stock, you’ll need to become a paid subscriber by clicking the button below. If you are already a paid subscriber, then we thank you for your support! Paid subscribers to the Dividend Informer receive completed featured stock write-ups each month, updates on covered companies, and market commentary from our award-winning team of analysts.